Reserve Bank of India – Tenders

[ad_1]

Read More/Less


Please refer to the tender notice published on the Bank’s website www.rbi.org.in on April 16, 2021, for Quotation for Non-Comprehensive Annual Maintenance Contract of Note Bundling Machines

2. It has been decided to extend the last date for submission of tender till May 18, 2021, 11:00 AM. The bids will be subsequently opened on May 18, 2021 12:00 noon.

3. It is clarified that all other terms and conditions shall remain unchanged.

Regional Director
Mumbai Regional Office
Reserve Bank of India,
Mumbai 400 001

[ad_2]

CLICK HERE TO APPLY

Group of Advisors to RBI’s Regulations Review Authority invites feedback and suggestions, BFSI News, ET BFSI

[ad_1]

Read More/Less


The Reserve Bank of India has set up a Regulations Review Authority (RRA 2.0) initially for a period of one year from May 01, 2021. The RRA will review the regulatory prescriptions internally and seek suggestions for simplification and ease of implementation from RBI controlled entities and other stakeholders.

The RRA has formed an Advisory Group made up of representatives from regulatory entities, including compliance officers, to help the RRA achieve the objectives set out in RRA 2.0’s terms of reference. The Group will assist by finding areas/regulations/guidelines/returns that can be rationalised and submitting reports to RRA with recommendations/suggestions on a regular basis. The composition of the Group is as under:

1. S. Janakiraman, Managing Director, State Bank of India Chairman
2. T. T. Srinivasaraghavan, Former MD & Non-Executive Director, Sundaram Finance Member
3. Gautam Thakur, Chairman, Saraswat Co-operative Bank Ltd. Member
4. Subir Saha, Group Chief Compliance Officer, ICICI Bank Ltd Member
5. Ravi Duvvuru, President & CCO, Jana Small Finance Bank Member
6. Abadaan Viccaji, Chief Compliance Officer, HSBC India Member

The Group has decided to invite feedback and suggestions from all regulated entities, industry bodies, and other stakeholders to undertake its preparatory work. Suggestions and feedback should be emailed latest by June 15, 2021, with the subject line Suggestions to the Advisory Group of RRA.

Follow and connect with us on , Facebook, Linkedin



[ad_2]

CLICK HERE TO APPLY

ESAF Small Finance Bank Revises Interest Rates On Fixed Deposit

[ad_1]

Read More/Less


Investment

oi-Vipul Das

|

Fixed deposit rates at ESAF Small Finance Bank are higher than savings account rates. The bank has recently revised fixed deposit (FD) interest rates, which are in force from May 2, 2021. The rate of interest on FDs for regular citizens varies from 4.00 percent to 6.5 percent after the most recent adjustment, for terms ranging from 7 days to 10 years. Senior citizens also get an extra 0.5 percent on their ESAF Small Finance term deposits, which have interest rates ranging from 4.5 percent to 7%. For a regular investor, the highest interest rate on an ESAF Bank FD is 6.5 percent for a period ranging from 365 days & 366 days, whereas the highest interest rate for senior citizens is 7% for the same period. The Deposit Insurance Scheme of the RBI insures all bank FDs. In addition, the insurance covers up to INR 5 lakhs. As a result, ESAF Small Finance Bank FD can be a good bet here. Fixed Deposits are interest-bearing investments that promise a guaranteed and risk-free return. As a result, investors can think about investing in an ESAF Small Finance Bank FD. Below are the updated ESAF Small Finance Bank FD interest rates.

ESAF Small Finance Bank Revises Interest Rates On Fixed Deposit

ESAF Small Finance Bank FD Rates

Tenure Regular FD Rates Senior Citizen FD Rates
7 days to 14 days 4.00% 4.50%
15 days to 59 days 4.50% 5.00%
60 days to 90 days 5.25% 5.75%
91 days to 181 days 5.50% 6.00%
182 days 5.00% 5.50%
183 days to 363 days 6.00% 6.50%
364 days 5.25% 5.75%
365 days & 366 days 6.50% 7.00%
367 days to 545 days 6.25% 6.75%
546 days 5.00% 5.50%
547 days to 727 days 6.25% 6.75%
728 days 5.25% 5.75%
729 days to 909 days 6.00% 6.50%
910 days 5.25% 5.75%
911 days to 1091 days 6.00% 6.50%
1092 days 5.25% 5.75%
1093 days to 1273 days 5.75% 6.25%
1275 -1455 days 5.25% 5.75%
1275 days -1455 days 5.75% 6.25%
1456 days 5.25% 5.75%
1457 days-1637 days 5.75% 6.25%
1638 days 5.25% 5.75%
1639 days-1819 days 5.75% 6.25%
1820 days 5.25% 5.75%
1821 days to 3653 days 5.25% 5.75%
Source: Bank Website



[ad_2]

CLICK HERE TO APPLY

Karnataka Bank will focus on cost-light liability portfolio, says MD

[ad_1]

Read More/Less


The Mangaluru-based Karnataka Bank navigated the challenges posed by the Covid pandemic last year, and earned a net profit of ₹451.20 crore in the first nine months of 2020-21 against the profit of ₹431.78 crore for the full year of 2019-20.

In an interview to BusinessLine, Mahabaleshwara MS, MD and CEO of the bank, highlighted the strategies that helped the bank to perform better, and its plans for the current financial year amidst the second Covid wave. Excerpts from interview:

India is witnessing the second wave of Covid. How is your bank planning to tackle this fresh challenge?

The first half of the last fiscal was spent in understanding and fighting the pandemic while the business was muted and there was no clear picture about the Covid pandemic. Our innovative business principle of ‘conserve, consolidate and emerge stronger’ immensely helped us to tide over the said crisis-like situation and be able to come out with satisfactory numbers. But now the situation is different. At least now, we have one year of experience in navigating through the pandemic and that is a huge advantage.

To overcome Covid wave 2.0, as in the previous fiscal, our bank will continue to practice the principle of ‘conserve, consolidate and emerge stronger’ along with the required cost cutting measures this year too. We will continue to be cautious and conservative. We will focus on developing a cost-light liability portfolio by concentrating more on CASA and low-cost retail term deposits besides developing a healthy asset portfolio which is largely protected against the ill effects of pandemic in the long run to tide over the economic challenges associated with the Covid wave 2.0.

Your recent letter to the shareholders mentioned that the bank is aiming at a ‘moderate’ growth of 12 per cent for 2021-22. What are the reasons for this moderate outlook?

Yes. The bank has set a moderate growth target of 12 per cent for business turnover for the current fiscal. Considering the Covid second wave that is sweeping the country with enormous impact on health and business in the short and medium term, we expect growth challenges in key sectors during the first half of the current year. Even though MSME and agriculture sectors are less impacted which are the main components of our retail loan book growth, the entire ecosystem of the economy already took a shock and it may need sufficient time to come out of this, if there are no more waves of Covid going forward.

We also expect the customers to be conservative in investing in new or big projects or expansion of business. Our focus will be to conserve, maintain the asset quality and grow steadily with quality during this fiscal. However, the bank will always be in a ‘ready mode’ to catch up business at any stage of economic rebound, beating our own guidance level. We have superior digital loan journey infrastructure and in a better position to encash such opportunities on the very first sight of economic turnaround.

Do you think the fresh Covid wave will lead to the increase in the NPAs in the coming days? If yes, how are you planning to handle that?

Even though the economic impact of the second wave of Covid pandemic and the related lockdowns ,etc have just started unfolding, no one can take it lightly and it may be too early to foresee the impact. The banking industry in India has fully exhibited its resilience and was able to face the challenges posed by the first wave of Covid, mainly because of the ‘economic vaccines’ in the form of regulatory packages such as moratorium, OTR / MSME restructuring, Emergency Credit Line Guarantee Scheme, charging of simple interest during moratorium, etc announced by the Government / Reserve Bank of India.

By opting for the said ‘economic vaccines’, the borrowers managed their cash flow with extended loan period. However, now the country is better placed with all its populace in the age group of 18 years and above are poised to get vaccines. Further, the borrowers have also remodelled their business and became more agile. However, it is also expected that revival and recovery may take more than the expected time. RBI has also recently announced a ‘booster dose’ with various relief measures both for the bankers as well as individual borrowers, small borrowers and MSMEs. This is expected to give the required impetus to the economy. Hence, the response for Covid 2.0 and going beyond, should be collective, comprehensive, decisive and long lasting besides forward looking.

Going by the current trend (until a major portion of India gets vaccinated), Covid waves are likely to recur at regular intervals. How is your bank planning to handle this?

The good news is that the Government has allowed vaccination for individuals aged 18 years and above. With vaccination initiatives and also with more awareness being created among the public about the this, it is hoped that maximum people would get vaccinated in about two-three months considering the current progress. It is expected that once the herd immunity is developed, the surge of Covid would also come down significantly. Like previous fiscal, our bank would continue to be cautious in lending and would ensure adding remunerative and quality assets besides focusing on a cost-light liability portfolio. Necessary steps will be taken at our disposal to protect the interest of all our stakeholders. With the strong fundamentals and improved capital adequacy ratio, we are confident of sailing smooth this year also in spite of unforeseen challenges.

Like earlier economic shocks such as the global recession, global financial crisis of 2007-08, this time too Indian banking sector, I am sure, will withstand the challenges and come out with flying colours. We will stand rock solid with the Government, RBI and the customers.

[ad_2]

CLICK HERE TO APPLY

Our strategy would be to focus on what we are doing well and spruce up our distribution, says Ageas Federal Life Insurance head

[ad_1]

Read More/Less


The surge in Covid infections in the second wave of the pandemic is likely to impact the life insurance sector in terms of new business, renewals, the persistency, claims, said Vighnesh Shahane, Managing Director and CEO, Ageas Federal Life Insurance. In an interview with BusinessLine, he outlined plans for the year and said the company will focus on distribution. Edited excerpts:

What are the prospects for life insurers given the impact of the second wave of Covid-19?

The first wave was an unknown entity and the worst we thought would be a lockdown and that economic mobility and the economy would be impacted. So we braced up for a loss of livelihood, lesser premium, lesser renewal and a little increase in mortality. This time around, its more lethal, and it’s going to impact the economy. It will impact the new business, renewals, the persistency, claims of insurance companies — life and health will go out of the roof.

With rising deaths, how will it impact the life insurance sector in terms of claims?

In the first wave, for our company at least, the mortality was in range. Mortality also depends on the lines of business, the market, the channels and the products offered. We were pretty conservative as we were not in the group business for term policies, we had withdrawn some products for adverse mortality experience. For example, we are not in the PM Jeevan Jyoti Yojana as we are not sure of the mortality. This time, the pandemic is impacting a younger cohort. And the infection and deaths in some of the markets where we are quite aggressive, like Kerala, Delhi, Mumbai and UP is picking up. I would expect our mortality claims to also spike. As of now, there’s no evidence. We’ve been tracking the second wave separately and internally.

What has been your total Covid claim?

Our total claims net of reinsurance for 2020-21 was about ₹84 crore, out of which Covid related was exactly 25 per cent at ₹21 crore. That’s representative of the industry. This wave, it could be a little more.

Going forward, what is the company’s strategy in terms of growth and products?

We just declared our results and we did well across all parameters, except topline to an extent. We did reasonably well in topline also but maybe not as well as three to four years ago when we had the full muscle of IDBI Bank. Our strategy would be to keep doing what we are doing well and spruce up our distribution. It could be a new banca partnership. Also, a focus on scaling up proprietary channels like agency, group, online, direct sales team. So the focus should be on distribution.

What is your distribution mix?

About 80 per cent is banca, out of which 99 per cent would be Federal Bank. Of the remaining, 10 per cent is agency, five per cent is direct sales and five per cent is group, online, brokerage.

Do you expect the demand for protection and term products to continue?

Protection products would be a focus because not only is there customer demand, but it’s also a very profitable product from an insurance company perspective. Our focus has always been on a balanced product mix. There is a segment of customers, especially Kerala and the HNIs who prefer ULIPs, and there are some lower end customers who take safety and prefer guaranteed returns, non participating guaranteed returns plans.

[ad_2]

CLICK HERE TO APPLY

Our strategy would be to focus on what we are doing well and spruce up our distribution, says Ageas Federal Life Insurance head

[ad_1]

Read More/Less


The surge in Covid infections in the second wave of the pandemic is likely to impact the life insurance sector in terms of new business, renewals, the persistency, claims, said Vighnesh Shahane, Managing Director and CEO, Ageas Federal Life Insurance. In an interview with BusinessLine, he outlined plans for the year and said the company will focus on distribution. Edited excerpts:

What are the prospects for life insurers given the impact of the second wave of Covid-19?

The first wave was an unknown entity and the worst we thought would be a lockdown and that economic mobility and the economy would be impacted. So we braced up for a loss of livelihood, lesser premium, lesser renewal and a little increase in mortality. This time around, its more lethal, and it’s going to impact the economy. It will impact the new business, renewals, the persistency, claims of insurance companies — life and health will go out of the roof.

With rising deaths, how will it impact the life insurance sector in terms of claims?

In the first wave, for our company at least, the mortality was in range. Mortality also depends on the lines of business, the market, the channels and the products offered. We were pretty conservative as we were not in the group business for term policies, we had withdrawn some products for adverse mortality experience. For example, we are not in the PM Jeevan Jyoti Yojana as we are not sure of the mortality. This time, the pandemic is impacting a younger cohort. And the infection and deaths in some of the markets where we are quite aggressive, like Kerala, Delhi, Mumbai and UP is picking up. I would expect our mortality claims to also spike. As of now, there’s no evidence. We’ve been tracking the second wave separately and internally.

What has been your total Covid claim?

Our total claims net of reinsurance for 2020-21 was about ₹84 crore, out of which Covid related was exactly 25 per cent at ₹21 crore. That’s representative of the industry. This wave, it could be a little more.

Going forward, what is the company’s strategy in terms of growth and products?

We just declared our results and we did well across all parameters, except topline to an extent. We did reasonably well in topline also but maybe not as well as three to four years ago when we had the full muscle of IDBI Bank. Our strategy would be to keep doing what we are doing well and spruce up our distribution. It could be a new banca partnership. Also, a focus on scaling up proprietary channels like agency, group, online, direct sales team. So the focus should be on distribution.

What is your distribution mix?

About 80 per cent is banca, out of which 99 per cent would be Federal Bank. Of the remaining, 10 per cent is agency, five per cent is direct sales and five per cent is group, online, brokerage.

Do you expect the demand for protection and term products to continue?

Protection products would be a focus because not only is there customer demand, but it’s also a very profitable product from an insurance company perspective. Our focus has always been on a balanced product mix. There is a segment of customers, especially Kerala and the HNIs who prefer ULIPs, and there are some lower end customers who take safety and prefer guaranteed returns, non participating guaranteed returns plans.

[ad_2]

CLICK HERE TO APPLY

RBI to Banks: Lend to healthcare space within 30 days of availing funds

[ad_1]

Read More/Less


The Reserve Bank of India (RBI) on Friday said Banks should lend to stakeholders in the Covid-related healthcare infrastructure and services within 30 days from the date of availing funds from it under the ₹50,000 crore“On-Tap Term Liquidity Facility to Ease Access to Emergency Health Services scheme”.

As per the scheme, there is no tenor restriction regarding lending by Banks. However, they will have to ensure that the amount borrowed from RBI should be backed by lending to the specified segments until the scheme’s maturity.

 

The scheme, which opens an on-tap liquidity window of ₹50,000 crore for Banks with tenors of up to three years at the repo rate till March 31, 2022, has been launched to boost immediate liquidity, ramping up Covid-related healthcare infrastructure and services in the country.

The scheme will remain operational from May 07, 2021, till March 31, 2022.

Scope of lending

Banks can provide fresh lending support to a wide range of entities under the scheme, including vaccine manufacturers; importers/ suppliers of vaccine and priority medical devices; hospitals/ dispensaries; pathology labs and diagnostic centres; manufacturers and suppliers of oxygen and ventilators; importers of vaccines and Covid-related drugs; Covid-related logistics firms and also patients for treatment.

RBI will aggregate requests from Banks and release funds every Monday (on the subsequent working day if Monday is a holiday) by initiating a 3-year repo contract with the requesting bank.

If a bank places multiple requests during the week, all such requests will be aggregated, and a single repo contract will be created on the date of operation.

The eligible collateral and margin requirements for availing funds under the scheme will remain the same as applicable for Liquidity Adjustment Facility operations.

Additional incentives

The central bank said Banks could park their surplus liquidity up to the size of the Covid loan book they build in a special 14-day reverse repo window to be conducted on each reporting Friday.

RBI will offer 40 basis points higher interest than the current reverse report rate on such liquidity.

The first such special reverse repo operation will be held on May 21, 2021. These 14-day reverse repo operations would continue till March 31, 2022 and will be reviewed thereafter.

Banks are being incentivised for quick delivery of credit under the scheme through the extension of priority sector lending (PSL) classification to such lending up to March 31, 2022.

RBI said Banks desirous of deploying their own resources without availing funds under the scheme for lending to the specified segments mentioned above would also be eligible for the additional incentives.

[ad_2]

CLICK HERE TO APPLY

LIC further relaxes claim settlement process

[ad_1]

Read More/Less


Amidst the second wave of the Covid-19 pandemic surging across the country, Life Insurance Corporation of India has further relaxed processes for settlement of claims.

To facilitate speedy settlement of death claims in the prevailing situation where death has occurred in a hospital, LIC will accept alternate proofs of death instead of a death certificate issued by the municipal authorities.

Alternate proofs of death would include death certificate, discharge summary or death summary containing clear date and time of death issued by the government, ESI, Armed Forces or corporate hospitals and counter-signed by LIC class I officers or Development Officers of 10 years standing along with the cremation or burial certificate or authentic identifying receipt issued by the relevant authority.

“In other cases, Municipal Death Certificate will be required as earlier,” LIC said in a statement on Friday.

Life certificates

For Annuities with return of capital options, production of life certificates is waived for annuities due up to October 21 this year, it further said.

LIC would also accept life certificates sent through email in other cases and has introduced life certificate procurement through video call process.

To address the difficulties experienced by policyholders in submitting documents required for claim settlement in servicing branch, submission of documents has been allowed in any nearby LIC office.

LIC further said that starting May 10, all its offices will work from Monday to Friday between 10 am and 5:30 pm. Saturdays will be a public holiday for LIC.

[ad_2]

CLICK HERE TO APPLY

Reserve Bank of India – Press Releases

[ad_1]

Read More/Less


    5.63% GS 2026 GOI FRB 2033 6.64% GS 2035 6.67% GS 2050
I. Notified Amount ₹11,000 cr ₹4,000 cr ₹10,000 cr ₹7,000 cr
II. Cut off Price / Implicit Yield at cut-off 100.36/5.5442% 98.50/4.8719% 100.47/6.5881% 98.09/6.8203%
III. Amount accepted in the auction ₹11,000 cr ₹4,000 cr ₹10,000 cr ₹7,000 cr
IV. Devolvement on Primary Dealers Nil Nil Nil Nil

Ajit Prasad
Director   

Press Release: 2021-2022/178

[ad_2]

CLICK HERE TO APPLY

1 76 77 78 79 80 100